Beyond FSP1 there are therapeutic opportunities across the CoQ 10 oxidoreductase network While FSP1 currently has the strongest targetability signal, other CoQ 10 oxidoreductases may be therapeutically leveraged in defined genetic, metabolic or tissue contexts: (1) DHODH axis (mitochondrial defense in select contexts): DHODH connects pyrimidine synthesis to mitochondrial CoQ reduction, and in some settings, DHODH inhibition has been proposed to heighten ferroptosis sensitivity, especially in GPX4-low states
We are both an online and physical store
Whether you're looking to brighten your complexion, support acne healing, or boost your immune system, this treatment offers a safe, effective, and efficient solution tailored to your needs
P., & Sloop, K
Capehorn MS, Catarig AM, Furberg JK, Janez A, Price HC, Tadayon S, Vergs B, Marre M
There isnt enough research to determine the efficacy and safety of these types of therapeutic agents